Supplementary Figure 1 from ROC1/RBX1 E3 Ubiquitin Ligase Silencing Suppresses Tumor Cell Growth Via Sequential Induction of G2-M Arrest, Apoptosis, and Senescence

Lijun Jia,Maria S. Soengas,Yi Sun

DOI: https://doi.org/10.1158/0008-5472.22378625.v1

2023-01-01

Abstract:Supplementary Figure 1 from ROC1/RBX1 E3 Ubiquitin Ligase Silencing Suppresses Tumor Cell Growth via Sequential Induction of G2-M Arrest, Apoptosis, and Senescence

What problem does this paper attempt to address?

Supplementary Figures 3-6 from an EBF3-Mediated Transcriptional Program That Induces Cell Cycle Arrest and Apoptosis

Lisa Y. Zhao,Yuxin Niu,Aleixo Santiago,Jilin Liu,Sara H. Albert,Keith D. Robertson,Daiqing Liao

DOI: https://doi.org/10.1158/0008-5472.22364391.v1

2023-01-01

Abstract:Supplementary Figures 3-6 from An EBF3-Mediated Transcriptional Program That Induces Cell Cycle Arrest and Apoptosis
Figure S5 from The E3 Ligase RING1 Targets p53 for Degradation and Promotes Cancer Cell Proliferation and Survival

Jiajia Shen,Pengyu Li,Xuejing Shao,Yang Yang,Xiujun Liu,Min Feng,Qiang Yu,Ronggui Hu,Zhen Wang

DOI: https://doi.org/10.1158/0008-5472.22418190.v1

2023-01-01

Abstract:Knockdown of RING1 suppresses cancer cell migration and inhibits tumor growth in vivo
Figure S4 from The E3 Ligase RING1 Targets p53 for Degradation and Promotes Cancer Cell Proliferation and Survival

Jiajia Shen,Pengyu Li,Xuejing Shao,Yang Yang,Xiujun Liu,Min Feng,Qiang Yu,Ronggui Hu,Zhen Wang

DOI: https://doi.org/10.1158/0008-5472.22418193

2023-01-01

Abstract:RING1 deficiency results in partial G1 arrest and p21 induction in the cells harboring wild-type p53, and its growth inhibitory effect is partially rescued by p53 silencing
Figure S1 from The E3 Ligase RING1 Targets p53 for Degradation and Promotes Cancer Cell Proliferation and Survival

Jiajia Shen,Pengyu Li,Xuejing Shao,Yang Yang,Xiujun Liu,Min Feng,Qiang Yu,Ronggui Hu,Zhen Wang

DOI: https://doi.org/10.1158/0008-5472.22418205

2023-01-01

Abstract:Efficiency of RING1 knockdown and its effect on the transcriptional activity of p21
RBX1/ROC1-SCF E3 Ubiquitin Ligase is Required for Mouse Embryogenesis and Cancer Cell Survival

Lijun Jia,Yi Sun

DOI: https://doi.org/10.1186/1747-1028-4-16

2009-01-01

Cell Division

Abstract:RBX1 (also known as ROC1) is a RING subunit of SCF (Skp1, Cullins, F-box proteins) E3 ubiquitin ligases, required for SCF to direct a timely degradation of diverse substrates, thereby regulating numerous cellular processes under both physiological and pathological conditions. Previous studies have shown that RBX1 is essential for growth in yeast, Caenorhabditis elegans and Drosophila. The role of RBX1 in mouse development and in regulation of cancer cell survival was unknown. Our recent work demonstrated that RBX1 is an essential gene for mouse embryogenesis, and targeted disruption of RBX1 causes embryonic lethality at E7.5 due to hypoproliferation as a result of p27 accumulation. We also showed that RBX1 is overexpressed in a number of human cancers, and siRNA silencing of RBX1 caused cancer cell death as a result of sequential induction of G2-M arrest, senescence and apoptosis. These findings reveal a physiological role of RBX1 during mouse development and a pathological role for the survival of human cancer cells. Differential outcomes between normal (growth arrest) and cancer cells (cell death) upon RBX1 disruption/silencing suggest RBX1 as a valid anticancer target.
Supplementary Figures 1-4 from Glioblastoma Proto-oncogene sec61γ is Required for Tumor Cell Survival and Response to Endoplasmic Reticulum Stress

Zhe‐Ming Lu,Lian Zhou,Patrick Killela,Ahmed Rasheed,Chunhui Di,William E. Poe,Roger E. McLendon,Darell D. Bigner,Christopher V. Nicchitta,Hai Yan

DOI: https://doi.org/10.1158/0008-5472.22383560.v1

2023-01-01

Abstract:Supplementary Figures 1-4 from Glioblastoma Proto-oncogene SEC61γ Is Required for Tumor Cell Survival and Response to Endoplasmic Reticulum Stress
Induction of Autophagy and Senescence by Knockdown of ROC1 E3 Ubiquitin Ligase to Suppress the Growth of Liver Cancer Cells

D Yang,L Li,H Liu,L Wu,Z Luo,H Li,S Zheng,H Gao,Y Chu,Y Sun,J Liu,L Jia

DOI: https://doi.org/10.1038/cdd.2012.113

IF: 12.067

2012-01-01

Cell Death and Differentiation

Abstract:Regulator of Cullins-1 (ROC1) or RING box protein-1 (RBX1) is an essential RING component of Cullin-RING ligase (CRL). Our previous studies showed that ROC1 is required for the growth of several cancer cell lines while ROC1 siRNA silencing inactivates CRL, leading to cell cycle arrest, cell senescence and/or apoptosis. However, it is completely unknown whether ROC1 knockdown triggers autophagic response by inactivating CRL. Moreover, the role of ROC1 in liver cancer remains elusive. In this study, we reported that ROC1 knockdown significantly inhibited the growth of liver cancer cells by sequentially and independently inducing autophagy and p21-dependent cell senescence. Mechanism analysis revealed that ROC1 silencing triggered autophagy by inhibition of mammalian target of rapamycin (mTOR) activity due to accumulation of mTOR-inhibitory protein Deptor, a substrate of CRL. Consistently, Deptor knockdown significantly blocked autophagy response upon ROC1 silencing. Biologically, autophagy response upon ROC1 silencing was a survival signal, and blockage of autophagy pathway sensitized cancer cells to apoptosis. Finally, we demonstrated that ROC1 was overexpressed in hepatocellular carcinomas, which is associated with poor prognosis of liver cancer patients. These findings suggest that ROC1 is an appealing drug target for liver cancer and provide a proof-of-concept evidence for a novel drug combination of ROC1 inhibitor and an autophagy inhibitor for effective treatment of liver cancer by enhancing apoptosis.
Dissecting the unique role of the retinoblastoma tumor suppressor during cellular senescence.

Agustin Chicas,Xiaowo Wang,Chaolin Zhang,Mila McCurrach,Zhen Zhao,Ozlem Mert,Ross A Dickins,Masashi Narita,Michael Zhang,Scott W Lowe

DOI: https://doi.org/10.1016/j.ccr.2010.01.023

IF: 50.3

2010-01-01

Cancer Cell

Abstract:The RB protein family (RB, p107, and p130) has overlapping and compensatory functions in cell-cycle control. However, cancer-associated mutations are almost exclusively found in RB, implying that RB has a nonredundant role in tumor suppression. We demonstrate that RB preferentially associates with E2F target genes involved in DNA replication and is uniquely required to repress these genes during senescence but not other growth states. Consequently, RB loss leads to inappropriate DNA synthesis following a senescence trigger and, together with disruption of a p21-mediated cell-cycle checkpoint, enables extensive proliferation and rampant genomic instability. Our results identify a nonredundant RB effector function that may contribute to tumor suppression and reveal how loss of RB and p53 cooperate to bypass senescence.
Targeting of the C-Jun/BCL-XL/P21 Axis Accelerates the Switch from Senescence to Apoptosis Upon ROC1 Knockdown in Gastric Cancer Cells

Ping Chen,Xiaoting Luo,Zhihui Che,Wenli Zhang,Fuchen Liu,Daisen Hou,Dongqin Yang,Jie Liu

DOI: https://doi.org/10.1159/000491979

2018-01-01

Cellular Physiology and Biochemistry

Abstract:BACKGROUND/AIMS Regulator of cullins-1 (ROC1) is a pivotal component of cullin-RING E3 ubiquitin ligases, which help to regulate distinct cellular processes by governing the degradation of various substrates. Because the role of ROC1 in gastric cancer is largely uncharacterized, we investigated the relationship between ROC1 expression and the prognosis of gastric cancer patients and explored the biological function of ROC1 and its underlying mechanisms in gastric cancer. METHODS Kaplan-Meier and multivariate Cox regression analyses were used to evaluate the correlation between the carcinogenesis of gastric cancer and ROC1. SA-β-gal staining and the senescence-associated secretory phenotype (SASP) were used to assess ROC1 silencing-induced cellular senescence. A xenograft zebrafish model was used to evaluate the effects of BCL-XL and ROC1 co-silencing on tumor formation in vivo. RESULTS High ROC1 expression was correlated with poor prognosis and a low 5-year survival rate of gastric cancer patients. ROC1 depletion significantly inhibited the growth of gastric cancer cells by sequentially inducing p21-mediated cellular senescence and mitochondrial-dependent apoptosis. Functional studies revealed successive upregulation of c-Jun, BCL-XL, and p21 upon ROC1 knockdown. BCL-XL suppression via RNA interference or a BH3 mimetic (ABT-737 or ABT-263) efficiently enhanced the anti-tumor effects of ROC1 knockdown. Equally as important, BCL-XL silencing strengthened ROC1 knockdown-induced apoptosis by blocking p21-mediated senescence. CONCLUSIONS The c-Jun/BCL-XL/p21 axis promotes senescence to resist ROC1 knockdown-induced apoptosis in gastric cancer cells. Targeted inactivation of BCL-XL could sensitize gastric cancer cells to ROC1 knockdown in clinical practice.
RBX1 (RING Box Protein 1) E3 Ubiquitin Ligase is Required for Genomic Integrity by Modulating DNA Replication Licensing Proteins.

Lijun Jia,Jeremy S. Bickel,Jiaxue Wu,Meredith A. Morgan,Hua Li,Jie Yang,Xiaochun Yu,Raymond C. Chan,Yi Sun

DOI: https://doi.org/10.1074/jbc.m110.188425

2011-01-01

Abstract:RBX1 (RING box protein 1), also known as ROC1 (Regulator of Cullin 1), is an essential component of SCF (Skp1/Cullins/F-box) E3 ubiquitin ligases, which target diverse proteins for proteasome-mediated degradation. Our recent study showed that RBX1 silencing triggered a DNA damage response (DDR) leading to G(2)-M arrest, senescence, and apoptosis, with the mechanism remaining elusive. Here, we show that, in human cancer cells, RBX1 silencing causes the accumulation of DNA replication licensing proteins CDT1 and ORC1, leading to DNA double-strand breaks, DDR, G(2) arrest, and, eventually, aneuploidy. Whereas CHK1 activation by RBX1 silencing is responsible for the G(2) arrest, enhanced DNA damage renders cancer cells more sensitive to radiation. In Caenorhabditis elegans, RBX-1 silencing causes CDT-1 accumulation, triggering DDR in intestinal cells, which is largely abrogated by simultaneous CDT-1 silencing. RBX-1 silencing also induces lethality during development of embryos and in adulthood. Thus, RBX1 E3 ligase is essential for the maintenance of mammalian genome integrity and the proper development and viability in C. elegans.
Inactivation of SAG or ROC1 E3 Ligase Inhibits Growth and Survival of Renal Cell Carcinoma Cells: Effect of BIM.

Yu Wang,Mingjia Tan,Hua Li,Haomin Li,Yi Sun

DOI: https://doi.org/10.1016/j.tranon.2019.03.002

IF: 4.803

2019-01-01

Translational Oncology

Abstract:SAG (Sensitive to Apoptosis Gene) and ROC1 (Regulator of Cullin-1) are two family members of the RING component of CRL (Cullin RING ligase). Both members are essential for growth and survival of several types of human cancer cells; their role in renal cell carcinoma (RCC), however, remains elusive. Here we reported that compared to adjacent normal tissues, both SAG and ROC1 are overexpressed in RCC, which is positively correlated with poor patient survival, particularly for SAG. Depletion of SAG or ROC1 inhibited growth and survival of RCC cells by inducing G2/M arrest, senescence, and apoptosis likely due to accumulation of WEE1, p21, p27, NOXA, and BIM. Interestingly, simultaneous BIM knockdown in RCC cells partially rescues growth suppression triggered by depletion of SAG, but not ROC1, suggesting a differential role of BIM. Collectively, our study provides the proof-of-concept evidence that RING components of CRL are attractive candidates for targeted therapy of RCC.
Supplementary Fig.4 from Nuclear Export of Ubiquitinated Proteins Determines the Sensitivity of Colorectal Cancer to Proteasome Inhibitor

Tingyu Wu,Wei Chen,Yongwang Zhong,Xiaodan Hou,Shengyun Fang,Chen-Ying Liu,Guanghui Wang,Tong Yu,Yu-Yang Huang,Xuesong Ouyang,Henry Q.X. Li,Long Cui,Yili Yang

DOI: https://doi.org/10.1158/1535-7163.22507974.v1

2023-01-01

Abstract:Nuclear p53 plays a critical role in synergistic cytotoxic effect in RKO cells.
Protective Autophagy Induced Byrbx1/roc1knockdown or CRL Inactivation Via Modulating the DEPTOR-MTOR Axis

Dongqin Yang,Yongchao Zhao,Jie Liu,Yi Sun,Lijun Jia

DOI: https://doi.org/10.4161/auto.22024

IF: 13.391

2012-01-01

Autophagy

Abstract:RBX1/ROC1 is an essential subunit of the largest multiunit Cullin-RING E3 ligase (CRL), which controls the degradation of diverse substrates, thereby regulating numerous cellular processes. Recently, we reported that RBX1 is overexpressed in hepatocellular carcinomas (HCC) and its expression is negatively correlated with patient survival. Moreover, siRNA silencing of RBX1 inhibits the proliferation of liver cancer cells both in vitro and in vivo by inducing CDKN1A/p21-dependent cell senescence. Interestingly, independent of senescence, RBX1 knockdown also triggers an autophagy response, due, at least in part, to the accumulation of the MTOR-inhibitory protein DEPTOR, a recently identified CRL substrate. Biologically, blockage of autophagy significantly enhances the growth-suppressive effect of RBX1 knockdown by triggering massive apoptosis, indicating that the autophagy response upon RBX1 knockdown serves as a survival signal in liver cells. Similar observations were also made in many types of human cancer cells upon inhibition of CRL by MLN4924. These findings suggest that RBX1-CRL is a promising anti-cancer drug target and provide proof-of-concept evidence for a novel drug combination of RBX1-CRL inhibitor and autophagy inhibitor for effective treatment of human cancer.
Protective Autophagy Induced by RBX1/ROC1 Knockdown or CRL Inactivation Via Modulating the DEPTOR-MTOR Axis.

Dongqin Yang,Yongchao Zhao,Jie Liu,Yi Sun,Lijun Jia

DOI: https://doi.org/10.4161/auto.22024

IF: 13.391

2012-01-01

Autophagy

Abstract:RBX1/ROC1 is an essential subunit of the largest multiunit Cullin-RING E3 ligase (CRL), which controls the degradation of diverse substrates, thereby regulating numerous cellular processes. Recently, we reported that RBX1 is overexpressed in hepatocellular carcinomas (HCC) and its expression is negatively correlated with patient survival. Moreover, siRNA silencing of RBX1 inhibits the proliferation of liver cancer cells both in vitro and in vivo by inducing CDKN1A/p21-dependent cell senescence. Interestingly, independent of senescence, RBX1 knockdown also triggers an autophagy response, due, at least in part, to the accumulation of the MTOR-inhibitory protein DEPTOR, a recently identified CRL substrate. Biologically, blockage of autophagy significantly enhances the growth-suppressive effect of RBX1 knockdown by triggering massive apoptosis, indicating that the autophagy response upon RBX1 knockdown serves as a survival signal in liver cells. Similar observations were also made in many types of human cancer cells upon inhibition of CRL by MLN4924. These findings suggest that RBX1-CRL is a promising anti-cancer drug target and provide proof-of-concept evidence for a novel drug combination of RBX1-CRL inhibitor and autophagy inhibitor for effective treatment of human cancer.
Validation of SAG/RBX2/ROC2 E3 Ubiquitin Ligase As an Anticancer and Radiosensitizing Target.

Lijun Jia,Jie Yang,Xinbao Hao,Min Zheng,Hongbin He,Xiufang Xiong,Liang Xu,Yi Sun

DOI: https://doi.org/10.1158/1078-0432.ccr-09-1592

IF: 13.801

2010-01-01

Clinical Cancer Research

Abstract:Purpose: Sensitive to apoptosis gene (SAG; also known as RBX2 or ROC2) was originally cloned as a redox-inducible antioxidant protein and was later characterized as a RING component of SCF E3 ubiquitin ligases. SAG overexpression inhibits apoptosis induced by many stimuli both in vitro and in vivo. SAG mRNA was overexpressed in human lung tumor tissues with a correlation to poor patient survival. To investigate whether SAG serves as an anticancer target, we determined the effect of SAG silencing on cell proliferation, survival, and radiosensitivity. Experimental Design: SAG protein expression in human tumors was evaluated by immunohistochemical staining using tumor tissue arrays. SAG expression in cancer cells was knocked down by siRNA silencing. The anticancer effects of SAG silencing were evaluated by in vitro assays for cell growth and survival and by an in vivo orthotopic xenograft tumor model. Radiosensitization by SAG silencing of human cancer cells was determined by clonogenic survival assay. Apoptosis induction was evaluated by fluorescence-activated cell sorting analysis, caspase-3 activation assay, and Western blotting of apoptosis-associated proteins. Results: SAG was overexpressed in multiple human tumor tissues compared with their normal counterparts. SAG silencing selectively inhibited cancer cell proliferation, suppressed in vivo tumor growth, and sensitized radiation-resistant cancer cells to radiation. Mechanistically, SAG silencing induced apoptosis with accumulation of NOXA, whereas SAG overexpression reduced NOXA levels and shortened NOXA protein half-life. Conclusions: The findings showed that SAG E3 ubiquitin ligase plays an essential role in cancer cell proliferation and tumor growth and may serve as a promising anticancer and radiosensitizing target. Clin Cancer Res; 16(3); 814–24
Supplementary Figure 3 from Dysfunction of Nucleus Accumbens-1 Activates Cellular Senescence and Inhibits Tumor Cell Proliferation and Oncogenesis

Yi Zhang,Yan Cheng,Xingcong Ren,Tsukasa Hori,Kathryn J. Huber-Keener,Li Zhang,Kai Lee Yap,David Liu,Lisa Shantz,Zheng-Hong Qin,Suping Zhang,Jianrong Wang,Hong-Gang Wang,Ie-Ming Shih,Jin-Ming Yang

DOI: https://doi.org/10.1158/0008-5472.22392809

2023-01-01

Abstract:PDF file - 190K, Silencing of p21 expression inhibits senescence induction in NAC1-deficient tumor cells treated with irradiation
Reexpression of the retinoblastoma protein in tumor cells induces senescence and telomerase inhibition

Hong-Ji Xu,Yunli Zhou,Wan Ji,Guang-Shing Perng,Russell Kruzelock,Cheng-Te Kong,Robert C Bast,Gordon B Mills,Jian Li,Shi-Xue Hu

DOI: https://doi.org/10.1038/sj.onc.1201446

IF: 8.756

1997-11-20

Oncogene

Abstract:Normal human diploid cells senesce in vitro and in vivo after a limited number of cell divisions. This process known as cellular senescence is an underlying cause of aging and a critical barrier for development of human cancers. We demonstrate here that reexpression of functional pRB alone in RB/p53-defective tumor cells via a modified tetracycline-regulated gene expression system resulted in a stable growth arrest at the G0/G1 phase of the cell cycle, preventing tumor cells from entering S phase in response to a variety of mitogenic stimuli. These cells displayed multiple morphological changes consistent with cellular senescence and expressed a senescence-associated β-galactosidase biomarker. Further studies indicated that telomerase activity, which was assumably essential for an extended proliferative life-span of neoplastic cells, was abrogated or repressed in the tumor cell lines after induction of pRB (but not p53) expression. Strikingly, when returned to an non-permissive medium for pRB expression, the pRB-induced senescent tumor cells resumed DNA synthesis, attempted to divide but most died in the process, a phenomenon similar to postsenescent crisis of SV40 T-antigen-transformed human diploid fibroblasts in late passage. These observations provide direct evidence that overexpression of pRB alone in RB/p53-defective tumor cells is sufficient to reverse their immortality and cause a phenotype that is, by all generally accepted criteria, indistinguishable from replicative senescence. The results suggest that pRB may play a causal role in the intrinsic cellular senescence program.

oncology,genetics & heredity,biochemistry & molecular biology,cell biology
Supplementary Figure 3 from Evidence for the Ubiquitin Protease UBP43 As an Antineoplastic Target

Yongli Guo,Fadzai Chinyengetere,Andrey V. Dolinko,Alexandra Lopez-Aguiar,Yun Lu,Fabrizio Galimberti,Tian Ma,Qing Feng,David Sekula,Sarah J. Freemantle,Angeline S. Andrew,Vincent Memoli,Ethan Dmitrovsky

DOI: https://doi.org/10.1158/1535-7163.22498668

2023-01-01

Abstract:PDF file, 677K, The siRNA-mediated repression of UBP43 induced apoptosis which is partially reversed by overexpressing cyclin D1 levels.
SUMOylation of Rb Enhances Its Binding with CDK2 and Phosphorylation at Early G1 Phase

Fengxi Meng,Jiang Qian,Han Yue,Xiaofeng Li,Kang Xue

DOI: https://doi.org/10.1080/15384101.2016.1182267

2016-01-01

Cell Cycle

Abstract:Retinoblastoma protein (Rb) is a prototypical tumor suppressor that is vital to the negative regulation of the cell cycle and tumor progression. Hypo-phosphorylated Rb is associated with G0/G1 arrest by suppressing E2F transcription factor activity, whereas Rb hyper-phosphorylation allows E2F release and cell cycle progression from G0/G1 to S phase. However, the factors that regulate cyclin-dependent protein kinase (CDK)-dependent hyper-phosphorylation of Rb during the cell cycle remain obscure. In this study, we show that throughout the cell cycle, Rb is specifically small ubiquitin-like modifier (SUMO)ylated at early G1 phase. SUMOylation of Rb stimulates its phosphorylation level by recruiting a SUMO-interaction motif (SIM)-containing kinase CDK2, leading to Rb hyper-phosphorylation and E2F-1 release. In contrast, a SUMO-deficient Rb mutant results in reduced SUMOylation and phosphorylation, weakened CDK2 binding, and attenuated E2F-1 sequestration. Furthermore, we reveal that Rb SUMOylation is required for cell proliferation. Therefore, our study describes a novel mechanism that regulates Rb phosphorylation during cell cycle progression.

Supplementary Figure 1 from ROC1/RBX1 E3 Ubiquitin Ligase Silencing Suppresses Tumor Cell Growth Via Sequential Induction of G2-M Arrest, Apoptosis, and Senescence

Supplementary Figures 3-6 from an EBF3-Mediated Transcriptional Program That Induces Cell Cycle Arrest and Apoptosis

Figure S5 from The E3 Ligase RING1 Targets p53 for Degradation and Promotes Cancer Cell Proliferation and Survival

Figure S4 from The E3 Ligase RING1 Targets p53 for Degradation and Promotes Cancer Cell Proliferation and Survival

Figure S1 from The E3 Ligase RING1 Targets p53 for Degradation and Promotes Cancer Cell Proliferation and Survival

RBX1/ROC1-SCF E3 Ubiquitin Ligase is Required for Mouse Embryogenesis and Cancer Cell Survival

Supplementary Figures 1-4 from Glioblastoma Proto-oncogene &lt;i&gt;sec61γ&lt;/i&gt; is Required for Tumor Cell Survival and Response to Endoplasmic Reticulum Stress

Induction of Autophagy and Senescence by Knockdown of ROC1 E3 Ubiquitin Ligase to Suppress the Growth of Liver Cancer Cells

Dissecting the unique role of the retinoblastoma tumor suppressor during cellular senescence.

Targeting of the C-Jun/BCL-XL/P21 Axis Accelerates the Switch from Senescence to Apoptosis Upon ROC1 Knockdown in Gastric Cancer Cells

RBX1 (RING Box Protein 1) E3 Ubiquitin Ligase is Required for Genomic Integrity by Modulating DNA Replication Licensing Proteins.

Inactivation of SAG or ROC1 E3 Ligase Inhibits Growth and Survival of Renal Cell Carcinoma Cells: Effect of BIM.

Supplementary Fig.4 from Nuclear Export of Ubiquitinated Proteins Determines the Sensitivity of Colorectal Cancer to Proteasome Inhibitor

Protective Autophagy Induced Byrbx1/roc1knockdown or CRL Inactivation Via Modulating the DEPTOR-MTOR Axis

Protective Autophagy Induced by RBX1/ROC1 Knockdown or CRL Inactivation Via Modulating the DEPTOR-MTOR Axis.

Validation of SAG/RBX2/ROC2 E3 Ubiquitin Ligase As an Anticancer and Radiosensitizing Target.

Supplementary Figure 3 from Dysfunction of Nucleus Accumbens-1 Activates Cellular Senescence and Inhibits Tumor Cell Proliferation and Oncogenesis

Reexpression of the retinoblastoma protein in tumor cells induces senescence and telomerase inhibition

Supplementary Figure 3 from Evidence for the Ubiquitin Protease UBP43 As an Antineoplastic Target

SUMOylation of Rb Enhances Its Binding with CDK2 and Phosphorylation at Early G1 Phase

Supplementary Figures 1-4 from Glioblastoma Proto-oncogene <i>sec61γ</i> is Required for Tumor Cell Survival and Response to Endoplasmic Reticulum Stress